日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incretin-based therapies for cardio-kidney-liver-metabolic disease: the role of the liver in the modern era of chronic disease management

基于肠促胰素的疗法治疗心肾肝代谢疾病:肝脏在现代慢性病管理中的作用

Elangovan, Harendran; Loomba, Rohit; Muthiah, Mark; Schattenberg, Jörn; Zheng, Ming Hua; Noureddin, Mazen; Mantzoros, Christos; George, Jacob

Guidelines for the evolving landscape of liver disease: From viral hepatitis to MAFLD

应对不断变化的肝病格局的指南:从病毒性肝炎到代谢性酒精性肝病

Elangovan, Harendran; George, Jacob

The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease

基于肠促胰素的药物疗法在治疗代谢功能障碍相关脂肪肝疾病方面展现出巨大潜力

Elangovan, Harendran; Gunton, Jenny Elizabeth; Zheng, Ming Hua; Fan, Jian-Gao; Goh, George Boon Bee; Gronbaek, Henning; George, Jacob

Vitamin D Receptor Regulates Liver Regeneration After Partial Hepatectomy in Male Mice

维生素D受体调节雄性小鼠部分肝切除术后的肝脏再生

Elangovan, Harendran; Stokes, Rebecca A; Keane, Jeremy; Chahal, Sarinder; Samer, Caroline; Agoncillo, Miguel; Yu, Josephine; Chen, Jennifer; Downes, Michael; Evans, Ronald M; Liddle, Christopher; Gunton, Jenny E

Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics

非酒精性脂肪肝病:初级保健与肝病专科门诊的衔接

Elangovan, Harendran; Rajagopaul, Sashen; Williams, Suzanne M; McKillen, Benjamin; Britton, Laurence; McPhail, Steven M; Horsfall, Leigh U; Valery, Patricia C; Hayward, Kelly L; Powell, Elizabeth E